Nohla Therapeutics

Seattle

Nohla Therapeutics is a Seattle-based therapeutics company that Ben Bergo previously co-founded.

Facts

HQ
Seattle
Sectors
Biotech, Therapeutics
Stage
Series B
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Nohla Therapeutics

See all 9

Seattle’s Deverra Therapeutics Raises $2.4M to Develop Cellular Immunotherapies with Fred Hutch License

Seattle biotech startup Deverra Therapeutics, founded by oncologist Colleen Delaney, is raising $2.4 million through debt and warrants to advance its cellular immunotherapy platform licensed from Fred Hutch. The company recently secured $3.5 million from the Andy Hill CARE Fund and licensed an immuno-oncology platform from Coeptis Therapeutics for $570,000 plus shares.

Questions about Nohla Therapeutics

What is Nohla Therapeutics?

Seattle

Who invested in Nohla Therapeutics, and how much has it raised?

Members of Seattle Flow see Nohla Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Nohla Therapeutics based?

Nohla Therapeutics is headquartered in Seattle.